cyclosaplin

General Information


DRACP ID  DRACP00490

Peptide Name   cyclosaplin

Sequence  RLGDGCTR

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  somatic seedlings of sandalwood

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=2.06 μg/mL MTT assay 24-72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Normal fibroblast (L929) cell line: Peptide (0–1000 μg/mL) did not exhibit any cytotoxicity.

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00490

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C33H60N14O12S

Absent amino acids  AEFHIKMNPQSVWY

Common amino acids  GR

Mass  100203

Pl  8.55

Basic residues  2

Acidic residues  1

Hydrophobic residues  1

Net charge  1

Boman Index  -3305

Hydrophobicity  -96.25

Aliphatic Index  48.75

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24503375

Title  Identification and structural characterization of a new pro-apoptotic cyclic octapeptide cyclosaplin from somatic seedlings of Santalum album L

Doi 10.1016/j.peptides.2014.01.023

Year  2014 

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.